Clinical Pathway Effectiveness: Febrile Young Infant Clinical Pathway in a Pediatric Emergency Department

Ashlee Lynn Murray1, Elizabeth Alpern, Jane Lavelle

  • 1From the *The Children's Hospital of Philadelphia, Philadelphia, PA; and †Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.

Pediatric Emergency Care
|January 11, 2017
PubMed

Insights

A standardized clinical pathway in the emergency department (ED) significantly improved the timeliness of care for febrile young infants. This pathway led to faster work-ups and earlier antibiotic administration, enhancing patient outcomes.

Area of Science:

  • Pediatrics
  • Emergency Medicine
  • Clinical Pathway Implementation

Background:

  • Febrile illnesses in young infants present diagnostic and management challenges in emergency departments (EDs).
  • Delays or ineffective care for febrile infants can increase morbidity and mortality.
  • Standardized clinical pathways are proposed to optimize care delivery.

Purpose of the Study:

  • To evaluate the impact of a clinical pathway for febrile young infants in a children's hospital ED.
  • To assess improvements in the timeliness and consistency of care.
  • To analyze the effect on diagnostic work-up and therapeutic interventions.

Main Methods:

  • A retrospective observational study design comparing before-and-after pathway implementation.
  • Inclusion criteria: infants ≤56 days old with rectal temperature ≥38.0°C.
  • Exclusion criteria: transfer patients or those developing fever post-presentation.

Main Results:

  • Pathway implementation reduced time to urine collection by 23 minutes and to first antibiotic by 36 minutes.
  • Increased proportion of infants receiving age-appropriate antibiotics (OR 7.2) and acyclovir (OR 8.8).
  • Demonstrated significant improvements in adherence to guideline-specific treatments.

Conclusions:

  • An ED-based clinical pathway for febrile young infants enhances care efficiency.
  • The pathway expedites diagnostic work-up (urine collection) and therapeutic interventions (antibiotics).
  • Implementation led to decreased variability and improved consistency in patient management.
Abstract

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.5K
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
979